CLINICAL ENCOUNTERS
ANTICOAGULATION
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
10 mg twice daily
|
|
|
10 mg once daily
|
|
|
5 mg once daily
|
|
|
5 mg twice daily
|
Detailed explanation-1: -Areas covered: Edoxaban and rivaroxaban are administered once daily, dabigatran and apixaban twice daily. The selection of these dosage regimens is largely based on studies for the prevention or treatment of venous thromboembolism or acute coronary syndrome.
Detailed explanation-2: -The recommended dose of ELIQUIS for most patients is 5 mg taken orally twice daily. The recommended dose of ELIQUIS is 2.5 mg twice daily in patients with at least two of the following characteristics: Â age greater than or equal to 80 years. body weight less than or equal to 60 kg.
Detailed explanation-3: -Anticoagulants. Anticoagulants (commonly referred to as “blood thinners”) are the medications most commonly used to treat DVT or PE. Although called blood thinners, these medications do not actually thin the blood.
Detailed explanation-4: -Reduction in the Risk of Recurrence of DVT and PE The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT or PE [see Clinical Studies (14.3)].